Lip cancer is gaining popularity. Scroll down to learn about the causes, risks, symptoms, and prevention of this cancer type ...

Sanofi and Regeneron's checkpoint inhibitor Libtayo has tripled its approved uses in Europe, after getting the nod for the treatment of advanced basal cell carcinoma (BCC) and advanced non-small ...

Identifying skin cancer risk through discussions with healthcare providers and dermatologists allows for timely interventions ...

Many Ugandans continue to face delayed diagnoses, limited access to specialised care, and low public awareness about eye ...

Discover the 7 key differences between harmless sunspots and dangerous skin cancer, plus essential prevention tips to protect ...

advanced squamous cell carcinoma (SCC), advanced basal cell carcinoma (BCC), advanced cutaneous squamous cell carcinoma (CSCC), and advanced non-small cell lung cancer (NSCLC). Last week ...

Artificial intelligence models, pretrained on vast datasets, significantly outperformed a standard baseline model in ...

Doctors discuss the prevalence, risks and treatments of metastatic melanoma, as Teddi Mellencamp reveals the latest updates ...

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Board of ...

Skinopathy turns to academic researchers to revolutionize dermatology in Canada, connecting patients to the right care at the ...

Now, patients with advanced melanoma are set to take part in a ... and the two most common are basal cell costs and squamous cell carcinoma," says Dr Anand. "They're much more common than melanomas ...